Your browser doesn't support javascript.
loading
Relapsed plasmablastic lymphoma in a HIV-negative patient: Pushing the envelope.
Kathrotiya, Manthan; Radhakrishnan, Vivek S; Bhave, Saurabh J; Kumar, Jeevan; Roychowdhury, Mita; Arun, Indu; Das, Jayanta; Chandy, Mammen; Nair, Reena.
Affiliation
  • Kathrotiya M; Clinical Haematology Oncology and HCT Tata Medical Center Kolkata India.
  • Radhakrishnan VS; Clinical Haematology Oncology and HCT Tata Medical Center Kolkata India.
  • Bhave SJ; Clinical Haematology Oncology and HCT Tata Medical Center Kolkata India.
  • Kumar J; Clinical Haematology Oncology and HCT Tata Medical Center Kolkata India.
  • Roychowdhury M; Clinical Haematology Oncology and HCT Tata Medical Center Kolkata India.
  • Arun I; Pathology Tata Medical Center Kolkata India.
  • Das J; Nuclear Medicine Tata Medical Center Kolkata India.
  • Chandy M; Clinical Haematology Oncology and HCT Tata Medical Center Kolkata India.
  • Nair R; Clinical Haematology Oncology and HCT Tata Medical Center Kolkata India.
Clin Case Rep ; 9(2): 873-877, 2021 Feb.
Article in En | MEDLINE | ID: mdl-33598263
This case emphasizes that, with the availability of novel immunotherapy agents (Daratumumab), and repurposed use of bortezomib, a patient with HIV-negative relapsed PBL can be treated successfully and consolidated with an allogeneic haploidentical hematopoietic cell transplantation.
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Case Rep Year: 2021 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Case Rep Year: 2021 Document type: Article Country of publication: United kingdom